{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-113.11",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 § 113.11 - Registered Organizations; General Requirements",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 § 113.11 - Registered Organizations; General Requirements\n\nState Regulations\n(a) In addition to the requirements in\n\nCannabis Law and as otherwise set forth in this Part, a registered organization\nshall: (1)\nmake its books, records, manufacturing and dispensing site architectural and engineering design\ndrawings, including a description of energy sources, type and location of\nengineering systems in use for heating, cooling, ventilation and electrical\ndistribution, water supply and sewage, policies and procedures, and\nmanufacturing and dispensing sites, available to the office or its authorized\nrepresentatives within 48 hours of notice for monitoring, except during\nunannounced inspections where such information shall be available to the Office\nimmediately upon request during the unannounced inspection, on-site inspection, and audit purposes, including but not limited to periodic inspections or\nevaluations of facilities, methods, procedures, materials, staff and equipment\nto assess compliance with requirements set forth in Article 3 of the Cannabis\n\nLaw and this Part. The operating plan and inventory tracking data must be\nonsite and readily accessible at each facility at all times; (2)\nonly manufacture and dispense medical\ncannabis products in New York State in accordance with Article 3 of the\n\nCannabis Law and this Part; (3)\nonly dispense medical cannabis products in an indoor, enclosed, secure facility\nlocated in New York State; (4)\nsubmit medical cannabis product(s), samples and manufacturing materials to the\n\nOffice upon request; (5)\nretain a\nsubset of each lot of medical cannabis product to allow for testing in the\nfuture if requested by the Office. The retained samples shall: (i) be stored unopened as indicated on the\nlabel and in the original packaging; (ii)\nbe readily identifiable as belonging to\nits specific lot; and\n(iii)\nbe a\nrepresentative quantity to allow for complete testing of the product at least\ntwo times and shall be retained by the registered organization for at least 30\ndays following the date of expiration. (6)\nimplement policies and procedures to\nnotify the Office within twenty-four (24) hours of the following: (i) any serious adverse events; (ii)\nany incident involving theft, loss or\npossible diversion of medical cannabis products; (iii)\nany suspected or known security breach\nor other facility event that may compromise public health and/or safety, or\nwhich requires response by public safety personnel or law\nenforcement; (iv)\nany recalls; and\n(v) any vehicle accidents or\nincidents occurring during transport of medical cannabis products. (7)\nwithin ten (10) days of the\noccurrence of one of the above events, the registered organization shall submit\na complete written incident report to the Office detailing the circumstances of\nthe event, any corrective actions taken, and where applicable, confirmation\nthat appropriate law enforcement authorities were notified. (8)\nquarantine any lot of medical cannabis\nproduct as directed by the Office, and not transport, distribute, dispense or\ndestroy such lot unless prior approval is obtained from the Office; (9)\ndispose of unusable medical cannabis\nproducts that have failed laboratory testing or any cannabis used in the\nmanufacturing process pursuant to section\n113.25\nof this Part; (10)\nmaintain records required by Article 3\nof the Cannabis Law and this Part for a period of five (5) years, unless\notherwise stated, and make such records available to the Office upon request. Such records shall include: (i) documentation, including lot numbers where applicable, of all materials used in the\nmanufacturing of the medical cannabis product to allow tracking of the\nmaterials, including but not limited to any hemp or hemp extract, soil, soil\namendment, nutrients, hydroponic materials, fertilizers, growth promoters, pesticides, fungicides, and herbicides; (ii)\ncultivation, manufacturing, packaging\nand labeling production records; and\n(iii)\nlaboratory testing results. (11)\npost the certificate of\nregistration issued by the Office in a conspicuous location on the premises of\neach manufacturing facility and dispensing site; (12)\namend its operating plan as directed by\nthe Office; (13)\nprovide all\nemployees with adequate training and proper safety equipment where necessary; and\n(14)\nimplement procedures to\nnotify the Office if the dispensing site closes during its normal hours of\noperation, the reason for the closure, and when the dispensing site is expected\nto resume normal hours of operation. (15)\nimplement policies and procedures for\noff-line dispensing of medical cannabis to patients in the event of a\ntechnological failure. (16)\nmaintain a staffing plan for staff involved in activities related to the\ncultivation of cannabis, the manufacturing or dispensing of medical cannabis\nproducts or staff with oversight responsibilities for such activities, which\nshall include: (i) a senior staff member with\na minimum of one (1) year experience in good agricultural practices (GAP) at\neach cultivation facility; (ii)\na\nquality assurance officer who shall exercise oversight of the organization's\npractices and procedures and who has documented training and experience in\nquality assurance and quality control procedures; (iii)\na requirement that all staff be 18\nyears of age or older. Any employee 18 years of age or older and under 21 years\nof age may not have direct interaction with certified patients inside a\nregistered organization's dispensing site; (iv)\na requirement that all staff involved in\nthe manufacturing of medical cannabis be trained in and conform to general\nsanitary practices; and\n(v) policies and procedures to ensure that the registered organization shall not be\nmanaged by or employ anyone who has been convicted within three years of the\ndate of hire, of any felony related to the functions or duties of operating a\nbusiness, unless the office determines that the manager or employee is\notherwise suitable to be hired as set forth in subdivision 7 of section 34 of\narticle 3, or section\n137\nof the\n\nCannabis Law. (b) Registered organizations registered under\narticle 3 of the Cannabis Law shall not: (1)\nconcurrently hold a license under article 4 of the Cannabis law; (2)\nsell adult-use cannabis or cannabis\nproducts to any licensee under article 4 of the Cannabis Law; (3)\ndispense medical cannabis products from\nthe same location where the cannabis is grown or manufactured, except for the\noperation of home delivery services where the operation of such services is\nconducted in compliance with the requirement of section\n113.13\nof this Part; (4)\ngrow cannabis or produce medical cannabis\nat any site other than a facility or site approved by the office as set forth\nin the registered organization's registration; (5)\nmake substantial alterations to the\nstructure or architectural design of a manufacturing or dispensing site, for\nwhich the office is authorized to issue guidance to further clarify what\nsubstantial alteration may mean, without prior written approval of the\noffice; (6)\nmake the following\nmodifications to a registered facility: (i) change the location without prior approval of the board; or\n(ii)\nexpand or reduce the size of a\nregistered facility without prior written approval of the office; (7)\nlocate a dispensing site in\nviolation of Part 119.4 of this Title; or\n(8)\nchange the name of the registered\norganization, including the name by which the organization does business, without receipt of prior written approval of the office. (c) In the event that a registered\norganization elects to cease operation of all permitted activities and\nsurrender its registration, the registered organization shall: (1)\nnotify the Office in writing at least 120\ndays prior to the anticipated date of closure of the manufacturing and each\ndispensing site. (2)\ninclude a\nproposed plan for closure in the written notice. The plan shall be subject to\n\nOffice approval in accordance with Office protocols, and shall include\ntimetables and describe the procedures and actions the registered organization\nshall take to: (i) notify affected certified\npatients and designated caregivers of the closure; (ii)\nproperly destroy, transfer or otherwise\ndispose of all the registered organization's supply of cannabis and medical\ncannabis products in accordance with the requirements set forth in section\n113.25\nof this Part; (iii)\nmaintain and make available to the\n\nOffice all records required to be maintained under this Part for a period of\nfive (5) years; and\n(iv)\nmaintain\ncompliance with these regulations and any other conditions required by the\n\nOffice until the approved closure date; (3)\n\nThe registered organization shall take no\naction to close a manufacturing or dispensing site prior to Office approval of\nthe plan for closure; and\n(4)\n\nThe\nregistered organization's failure to notify the Office of intent to cease any\noperations, failure to submit an approvable plan, and/or to execute the\napproved plan may result in the imposition of civil penalties, not to exceed\n$2,000, and shall be a basis for the Board to revoke the registration of the\nregistered organization under such terms as the Board determines is appropriate\nbased on public health and safety considerations. In addition, the Office\nreserves the right to exercise any other remedies available to it. (d) Registered organizations shall\ncomply with all requirements for worker health and safety standards in\naccordance with Part 125.6 of this Title. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\n§\n113.11\n\nAdopted\n\nNew\n\nYork State Register February 22, 2023/Volume XLV, Issue 08, eff. 2/22/2023\n\nAmended\n\nNew\n\nYork State Register March 27, 2024/Volume XLVI, Issue 13, eff. 3/27/2024\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. (a) In addition to the requirements in Cannabis\n\nLaw\nand as otherwise set forth in this Part, a\nregistered organization\nshall: (1)\nmake its books, records, manufacturing\nand dispensing\nsite\narchitectural and engineering design drawings, including a description of energy sources, type and location of engineering systems in use for heating, cooling, ventilation and electrical distribution, water supply and sewage, policies and procedures, and\nmanufacturing\nand dispensing sites, available to the\n\nOffice\nor its authorized representatives within 48 hours of notice for monitoring, on-\nsite\ninspection, and audit purposes, including but not limited to periodic inspections or evaluations of facilities, methods, procedures, materials, staff and equipment to assess compliance with requirements set forth in Article 3 of the Cannabis\n\nLaw\nand this Part. The operating\nplan\nmust be onsite and readily accessible at each facility at all times; (2)\nonly manufacture and dispense medical cannabis products in New York\n\nState\nin accordance with Article 3 of the Cannabis\n\nLaw\nand this Part; (3)\nonly dispense medical cannabis products in an\nindoor, enclosed, secure facility located in New York\n\nState; (4)\nsubmit\nmedical cannabis product\n(s), samples and\nmanufacturing\nmaterials to the\n\nOffice\nupon request; (5)\nretain a subset of each\nlot\nof\nmedical cannabis product\nto allow for testing in the future if requested by the\n\nOffice. The retained samples shall: (i) be stored unopened as indicated on the label and in the original packaging; (ii)\nbe readily identifiable as belonging to its specific\nlot; and\n(iii)\nbe a statistically representative quantity to allow for complete testing of the product at least two (2) times and shall be retained by the\nregistered organization\nfor at least thirty (30) days following the\ndate of expiration. (6)\nimplement policies and procedures to notify the\n\nOffice\nwithin twenty-four (24) hours of the following: (i) any serious adverse events; (ii)\nany incident involving theft, loss or possible diversion of medical cannabis products; (iii)\nany suspected or known security breach or other facility event that\nmay\ncompromise public health and/or safety, or which requires response by public safety personnel or\nlaw\nenforcement; and\n(iv)\nany vehicle accidents or incidents occurring during transport of medical cannabis products; and\n(7)\nwithin ten (10) days of the occurrence of one of the above events, the\nregistered organization\nshall submit a complete written incident report to the\n\nOffice\ndetailing the circumstances of the event, any corrective actions taken, and where applicable, confirmation that appropriate\nlaw\nenforcement authorities were notified. (8)\nquarantine any\nlot\nof\nmedical cannabis product\nas directed by the\n\nOffice, and not transport, distribute, dispense or destroy such\nlot\nunless prior approval is obtained from the\n\nOffice; (9)\ndispose of unusable medical cannabis products that have failed laboratory testing or any cannabis used in the\nmanufacturing\nprocess pursuant to section\n113.25\nof this Part; (10)\nmaintain records required by Article 3 of the Cannabis\n\nLaw\nand this Part for a period of five (5) years, unless otherwise stated, and make such records available to the\n\nOffice\nupon request. Such records shall include: (i) documentation, including\nlot\nnumbers where applicable, of all materials used in the\nmanufacturing\nof the\nmedical cannabis product\nto allow tracking of the materials, including but not limited to, soil, soil amendment, nutrients, hydroponic materials, fertilizers, growth promoters, pesticides, fungicides, and herbicides; (ii)\ncultivation, manufacturing, packaging and labeling production records; and\n(iii)\nlaboratory testing results. (11)\npost the certificate of registration issued by the\n\nOffice\nin a conspicuous location on the premises of each\nmanufacturing\nfacility and dispensing\nsite; (12)\namend its operating\nplan\nas directed by the\n\nOffice; (13)\nprovide all employees with adequate training and proper safety equipment where necessary; and\n(14)\nimplement procedures to notify the\n\nOffice\nif the dispensing\nsite\ncloses during its normal hours of operation, the reason for the closure, and when the dispensing\nsite\nis expected to resume normal hours of operation. (b) Registered organizations shall not: (1)\ndispense medical cannabis products from the same location where the cannabis is grown or manufactured, except for the operation of home delivery services; (2)\ngrow cannabis or produce medical cannabis at any\nsite\nother than a facility or\nsite\napproved by the\n\nOffice\nas set forth in the\nregistered organization\n's registration; (3)\ndistribute products or samples at no cost except as\nmay\nbe allowed by the\n\nOffice; (4)\nmake substantial alterations to the\nstructure\nor architectural design of a\nmanufacturing\nor dispensing\nsite\nwithout prior written approval of the\n\nOffice; (5)\nmake the following modifications to a registered facility: (i) change the location without prior approval of the\n\nBoard; or\n(ii)\nexpand or reduce the size of a registered facility without prior written approval of the\n\nOffice; (6)\nmaterially modify or revise its operating\nplan, including its policies and procedures, without filing the revised operating\nplan\nin a manner as prescribed by the\n\nOffice; (7)\nlocate a dispensing\nsite\non the same street or avenue and within five hundred (500) feet of\nschool grounds\nas such term is defined in the Education\n\nLaw\nor two hundred (200) feet from a\nhouse of worship. The measurements in this paragraph\nof this subdivision\nare to be taken in straight lines from the center of the nearest entrance of the premises sought to be used as a dispensing\nsite\nused by certified patients or designated caregivers to enter to the nearest point of the\nschool grounds\nor\nhouse of worship; or\n(8)\nchange the name of the\nregistered organization, including the name by which the organization does business, without receipt of prior written approval of the\n\nOffice. (c) In the event that a\nregistered organization\nelects to cease operation of all permitted activities and surrender its registration, the\nregistered organization\nshall: (1)\nnotify the\n\nOffice\nin writing at least 120 days prior to the anticipated date of closure of the\nmanufacturing\nand each dispensing\nsite. (2)\ninclude a proposed\nplan\nfor closure in the written notice. The\nplan\nshall be subject to\n\nOffice\napproval in accordance with\n\nOffice\nprotocols, and shall include timetables and describe the procedures and actions the\nregistered organization\nshall take to: (i) notify affected certified patients and designated caregivers of the closure; (ii)\nproperly destroy, transfer or otherwise dispose of all the\nregistered organization\n's supply of cannabis and medical cannabis products in accordance with the requirements set forth in section\n113.25\nof this Part; (iii)\nmaintain and make available to the\n\nOffice\nall records required to be maintained under this Part for a period of five (5) years; and\n(iv)\nmaintain compliance with these regulations and any other conditions required by the\n\nOffice\nuntil the approved closure date; (3)\n\nThe\nregistered organization\nshall take no action to close a\nmanufacturing\nor dispensing\nsite\nprior to\n\nOffice\napproval of the\nplan\nfor closure; and\n(4)\n\nThe\nregistered organization\n's failure to notify the\n\nOffice\nof intent to cease any operations, failure to submit an approvable\nplan, and/or to execute the approved\nplan\nmay\nresult in the imposition of civil penalties, not to exceed $2,000, and shall be a basis for the\n\nBoard\nto revoke the registration of the\nregistered organization\nunder such terms as the\n\nBoard\ndetermines is appropriate based on public health and safety considerations. In addition, the\n\nOffice\nreserves the right to exercise any other remedies available to it. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\n§\n113.11\n\nAdopted\n\nNew York\n\nState\n\nRegister February 22, 2023/Volume XLV, Issue 08, eff. 2/22/2023",
  "url_type": "regulation",
  "source_index": 13229
}